One surface plasmon resonance study demonstrated that serotonin could facilitate monomeric Aβ binding to serum albumin, which was hypothesized to be a promising way to prevent the onset and progression of AD (Litus et al., 2021). This evidence concerns the gene ALB and Alzheimer disease.